Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 6/20 | 0.62 |
| ▸ | CTSL | P07711 | 5/20 | 0.62 |
| ▸ | CTSS | P25774 | 5/20 | 0.62 |
| ▸ | CTSB | P07858 | 4/20 | 0.62 |
| ▸ | REN | P00797 | 1/20 | 0.52 |
| ▸ | LTA4H | P09960 | 1/20 | 0.52 |
| ▸ | CASP1 | P29466 | 1/20 | 0.50 |
| ▸ | MME | P08473 | 1/20 | 0.48 |
| ▸ | ACE | P12821 | 1/20 | 0.48 |
| ▸ | CPA1 | P15085 | 1/20 | 0.48 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4800376 | 0.90 | CTSK (0.67) | CTSKCTSLCTSSCTSBLTA4H | |
| SCHEMBL28546631 | 0.90 | CTSK (0.67) | CTSKCTSLCTSSCTSBLTA4H | |
| SCHEMBL4622697 | 0.90 | CTSK (0.67) | CTSKCTSLCTSSCTSBLTA4H | |
| SCHEMBL25282430 | 0.89 | CTSK (0.65) | CTSKCTSLCTSSCTSBLTA4H | |
| SCHEMBL25282429 | 0.89 | CTSK (0.65) | CTSKCTSLCTSSCTSBLTA4H | |
| SCHEMBL15649121 | 0.86 | CTSK (0.62) | CTSKCTSLCTSSCTSBLTA4H | |
| SCHEMBL22122405 | 0.86 | CTSK (0.62) | CTSKCTSLCTSSCTSBLTA4H | |
| SCHEMBL7331686 | 0.85 | CTSK (0.65) | CTSKCTSLCTSSCTSBREN | |
| SCHEMBL7299710 | 0.85 | CTSK (0.65) | CTSKCTSLCTSSCTSBREN | |
| SCHEMBL25285983 | 0.85 | CTSL (0.64) | CTSKCTSLCTSSCTSBLTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1200457-B1 | CYSTEINE PROTEASE INHIBITORS | NAEJA PHARMACEUTICAL INC (CA) | 2004-08-25 | — | — | EP | disclosed |
| US-6635621-B1 | Alpha amino acid amide derivatives; reducing cathepsins B, L, S and/or K activity | NAEJA PHARMACEUTICAL INC. (CA) | 2003-10-21 | — | — | US | disclosed |
| EP-1200457-A2 | CYSTEINE PROTEASE INHIBITORS | Naeja Pharmaceutical Inc. (CA) | 2002-05-02 | — | — | EP | disclosed |
| WO-2001009169-A2 | CYSTEINE PROTEASE INHIBITORS | NAEJA PHARMACEUTICAL INC (CA) | 2001-02-08 | — | — | WO | disclosed |